醫藥行業的數字技術PLM產品研發生命周期管理系統，PLM為什么適用醫藥行業
醫藥行業的數字技術PLM系統,PLM為什么適用醫藥行業？數字化轉型網有關于醫藥行業的數字化轉型資料及數字化轉型案例。
依據IPD管理理念，對標 “醫藥行業” 研發管理模式，建立PLM系統研發項目管理平臺，使醫藥企業實現從“項目啟動、項目規劃、項目執行、項目監控、項目收尾”的完整生命周期管控。PLM系統使醫藥企業實現業務環節的數據打通，PLM系統使醫藥企業共享完整的研發信息，PLM系統使醫藥企業提升各階段/環節的研發任務效率。
PLM系統幫助醫藥企業提升具體包括：
1、PLM系統使醫藥企業標準化：為了提升研發業務的標準化與規范化管理，PLM系統建立對標管理模式，PLM系統以標準驅動研發業務的開展，PLM系統降低人為因素對業務的干擾，同時不斷優化與積累醫藥項目中的經驗，通過對標準的積累，包括進度組織標準、流程標準、交付成果標準，最終實現項目的過程與標準的無縫對接與融合。
2PLM系統使醫藥企業協作效率提高：為了縮短研發項目的時間，PLM系統建立PMO與PI二級的任務管控模式，在系統可自動化的按研發的業務過程，對資源分發與其相關的任務內容，并關聯其任務開展所需要的所有要素（如：流程、交付成果、注意風險等），減少PMO與PI在項目中的協調與管理成本，加速研發項目的開展的效率。
3、PLM系統使醫藥企業減少過程風險：為了避免研發過程中產生的風險事項，PLM系統建立問題與風險監督體系，通過PLM系統醫藥企業可監控計劃與執行偏差、項目的風險識別與整改，動態化預警出現的問題和風險，提升醫藥企業項目的風險控制能力。
4、PLM系統使醫藥企業降低人力資源成本：為了降低研發過程中的人力資源成本，PLM建立人才的大數據庫，并聯動醫藥企業項目的品類管線與重要等級維度，使醫藥企業做到項人匹配，同時為了激勵醫藥企業人員的積極性，建立量化的績效分配模式，以醫藥企業內部人員參與里程碑完成的質量與周期作為評定標準，量化考核人員的研發產出，便于領導對優秀人才的選拔與激勵。
根據數字化轉型網（搜索欄輸入：中國數字化轉型網，即可了解詳情）的資料，PLM是企業數字化轉型非常重要的一環。根據數字化轉型網的PLM研究報告，PLM是醫藥、化工行業、服裝行業、機械裝備制造業行業、電子機電行業、汽車、汽車零部件行業、家具家電、消費品等行業企業必須具備的管理系統軟件，在行業數字化轉型中起到非常重要的作用。
數字化轉型網也提供大量的關于PLM報告、數字化轉型資料報告，如果您想了解更多關于數字化轉型的知識、方案、報告、資料，建議一定要去看看哦。?
翻譯
The digital technology PLM system of medicine industry, why PLM is suitable for medicine industry? Digital transformation network has digital transformation information and digital transformation cases about the pharmaceutical industry.
According to the IPD management concept, the research and development management mode of "pharmaceutical industry" is standardized, and the PLM system research and development project management platform is established, so that pharmaceutical enterprises can realize the complete life cycle control from "project start, project planning, project execution, project monitoring and project closure". PLM system enables pharmaceutical enterprises to achieve business link data access, PLM system enables pharmaceutical enterprises to share complete research and development information, PLM system enables pharmaceutical enterprises to improve the efficiency of research and development task at each stage/link.?
PLM system helps pharmaceutical enterprises improve, including:
1. PLM system standardizes pharmaceutical enterprises: In order to improve the standardization and standardized management of R&D business, PLM system establishes a benchmarking management mode. PLM system drives the development of R&D business by standards, reduces the interference of human factors on business, and continuously optimizes and accumulates experience in pharmaceutical projects. Through the accumulation of standards, including schedule organization standards, process standards, and deliverable standards, The final realization of the project process and standard seamless docking and integration.
2. PLM system improves the collaboration efficiency of pharmaceutical enterprises: In order to shorten the time of R&D projects, PLM system establishes the PMO and PI level task management and control mode, in which the system can automatically distribute its related tasks according to the business process of R&D, and associate all the elements required for its task development (such as: Process, deliverables, attention to risks, etc.), reduce the coordination and management costs of PMO and PI in the project, and accelerate the efficiency of R&D projects.
3. PLM system enables pharmaceutical enterprises to reduce process risks: In order to avoid risks arising in the process of research and development, PLM system establishes a problem and risk supervision system. Through PLM system, pharmaceutical enterprises can monitor deviations from plan and execution, identify and rectify project risks, dynamically warn problems and risks, and improve the risk control ability of pharmaceutical enterprises.
4. PLM system enables pharmaceutical enterprises to reduce human resource costs: In order to reduce the cost of human resources in the process of research and development, PLM establishes a large database of talents, and links the category pipeline and important level dimension of the pharmaceutical enterprise project, so that the pharmaceutical enterprise can match the project personnel. At the same time, in order to stimulate the enthusiasm of the pharmaceutical enterprise personnel, it establishes a quantitative performance distribution model. With the quality and cycle of the pharmaceutical enterprise's internal personnel participating in the completion of milestones as the evaluation criteria, the quantitative assessment of personnel's R & D output is convenient for leaders to select and motivate outstanding talents.
